Dr. Ioannis Tarnanas, Ph.D. - Founder - Altoida, Inc. | LinkedIn
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Dr. Ioannis Tarnanas, Ph.D. - Founder - Altoida, Inc. | LinkedIn
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Ιωάννης Ταρνανάς - Έλληνας ερευνητής κέρδισε ΕΙΤ Innovators Award | ellines.com
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED
Altoida, Inc. - Contacts, Employees, Board Members, Advisors & Alumni
Greek Researcher Receives Top European Innovation Award (video)
Altoida - Diagnosing Alzheimer's Disease 5 years prior to it's onset using Augmented Reality on your iPhone | Startup Ranking
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
New Alzheimer's Prediction Smartphone App Gets FDA Breakthrough Status - Being Patient
Altoida secures funding and research partnership with Eisai Innovation – Venturelab
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Altoida, Inc. - Contacts, Employees, Board Members, Advisors & Alumni
A brain fitbit that can spot Alzheimer's with up to 94% accuracy
Cognitive Health & Digital Biomarker Technologies | Altoida
Cognitive Health & Digital Biomarker Technologies | Altoida
Ioannis Tarnanas - Worldwebforum
Alzheimer's detection platform Altoida raises $6.3M in Series A funding | MobiHealthNews
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
